Key Takeaways Lilly stock surged 16% last week amid optimism following Pfizer's federal agreement announcement.The Pfizer deal eased investor concerns over drug pricing and tariffs in the pharma sector.Lilly's $27B U.S. expansion aims to boost production of Mounjaro and Zepbound medicines.Shares of Eli Lilly (LLY) have surged 16% in the past week, driven primarily by positive investor expectations around the broader pharmaceutical sector after Pfizer (PFE) announced a landmark agreement with the Trump admin ...

Key Takeaways AbbVie shares jumped 6% last week, adding $23.5B in market value amid sector-wide investor optimism.Pfizer's new pricing and tariff deal with the Trump administration boosted sentiment across Big Pharma.ABBV plans over $10B in U.S. investments, including a $70M expansion at its Worcester, MA, facility.Shares of AbbVie (ABBV) gained 6% last week, translating to roughly $23.5 billion in market value. This upside was primarily driven by investor optimism around the broader pharmaceutical sector a ...